NN
Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
$0.00 +0.00% (+$0.00)
Market Cap 21.5K €
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
95 /100
Cheap EV/EBITDA 2.00x
P/S 0.00x
P/B 0.00x
Growth
9 /100
Declining Book val. growth 3.29%
Rev. growth 33.29%
FCF growth N/A
Profitability
82 /100
Strong Net margin 9.35%
Op. margin 22.27%
Gross margin 45.07%
Quality
60 /100
Average ROA 5.92%
Asset turnover 0.63x
ROIC 11.66%
Debt
41 /100
Moderate Current ratio 1.12x
Int. coverage 3.73x
Net debt/EBITDA 2.00x
Stability
44 /100
Moderate Rev. volatility 22.18%
Profitable years 1
Beta -8.83x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NNBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Stanton
Employees
1
Headquarters
Tampa